drugset / Trial / NCT07523347
Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis
RandomizedParallel-groupOpen-labelTreatment
Summary
The study seeks to fill the gaps regarding safety and efficacy of rivaroxaban and standard anticoagulant. therefore the current study was planned with the aim to determine the safety and efficacy of rivaroxaban and standard anticoagulant in the treatment of cerebrosinovenous thrombosis (CSVT).
Timeline
- Start
- 2023-12-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivaroxaban | Other / unclassified | — | Oral |
| Subject | Warfarin | Small molecule | — | Oral |